Potential of Artificial Intelligence to Accelerate Drug Development for Rare Diseases
- 5 February 2024
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Medicine
- Vol. 38 (2) , 79-86
Abstract
The growth in breadth and depth of artificial intelligence (AI) applications has been fast, running hand in hand with the increasing amount of digital data available. Here, we comment on the application of AI in the field of drug development, with a strong focus on the specific achievements and challenges posed by rare diseases. Data paucity and high costs make drug development for rare diseases especially hard. AI can enable otherwise inaccessible approaches based on the large-scale integration of heterogeneous datasets and knowledge bases, guided by expert biological understanding. Obstacles still exist for the routine use of AI in the usually conservative pharmaceutical domain, which can easily become disillusioned. It is crucial to acknowledge that AI is a powerful, supportive tool that can assist but not replace human expertise in the various phases and aspects of drug discovery and development.Keywords
This publication has 39 references indexed in Scilit:
- Orphan drugs: major development challenges at the clinical stageDrug Discovery Today, 2019
- A Computational Framework for Genome-wide Characterization of the Human Disease LandscapeCell Systems, 2019
- Machine Learning-based Virtual Screening and Its Applications to Alzheimer’s Drug Discovery: A ReviewCurrent Pharmaceutical Design, 2018
- Development of an evidence-based algorithm that optimizes sensitivity and specificity in ES-based diagnostics of a clinically heterogeneous patient populationGenetics in Medicine, 2018
- Explaining Therapy Predictions with Layer-Wise Relevance Propagation in Neural Networks2018
- Large-scale computational drug repositioning to find treatments for rare diseasesnpj Systems Biology and Applications, 2018
- Navigation and Robotics in Spinal Surgery: Where Are We Now?Neurosurgery, 2017
- Adenomatous Polyposis Syndromes: Diagnosis and ManagementClinics in Colon and Rectal Surgery, 2016
- Analysis of Machine Learning Techniques for Heart Failure ReadmissionsCirculation: Cardiovascular Quality and Outcomes, 2016
- The effectiveness of virtual reality distraction for pain reduction: A systematic reviewClinical Psychology Review, 2010